best cbd oil canada

Ayurcann Holdings Corp. Continues its Medical Cannabis Strategy With The Herb Clinic

Ayurcann Holdings Corp. (CSE: AYUR) (FSE:3ZQ0) (the " Company " or " Ayurcann ") a Canadian cannabis extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, is pleased to announce that it has entered into a patient-referral agreement with The Herb Clinic (" Clinic "), providing Canadians guidance and access to managing discomfort with medicinal cannabis.

The Herb Clinic has over 4000 patients registered and is comprised of compassionate and knowledgeable service providers who are defined by their ability to provide exceptional patient care. They help educate and integrate cannabis into the patient's medical treatment plans and partner with medicinal cannabis providers such as Ayurcann, to ensure their patients are getting top-quality advice with exceptional value.

The terms of the agreement will see The Herb Clinic send medical cannabis patients to Ayurcann through a patient education agreement. Ayurcann will work with the patients to educate them on their available offerings and help them select appropriate products.

A Media Snippet accompanying this announcement is available by clicking on the image or link below :

"Working with the leaders in the industry is what we strive towards, being able to partner with and enhance cannabis education, provide the best possible value, national coverage, while expending our offerings for the best national and international brands for THC and CBD based products to patients is making Ayurcann and Ayurcann marketplace a leader in the industry," commented Igal Sudman, CEO of Ayurcann.

For further information, please contact:
Igal Sudman, Chairman, Chief Executive Officer
Ayurcann Holdings Corp.
Tel: 905-492-3322
Email: infol@Ayurcann.com

Investor Relations:
Ryan Bilodeau
Tel: 416-910-1440
Email: ir@Ayurcann.com

About Ayurcann Holdings Corp.:
Ayurcann is a leading post-harvest solution provider with a focus on providing and creating custom processes and pharma grade products for the adult use and medical cannabis industry in Canada. Ayurcann is focused on becoming the partner of choice for leading Canadian cannabis brands by providing best-in-class, proprietary services including ethanol extraction, formulation, product development and custom manufacturing.

Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release.

Certain statements included in this press release constitute forward-looking information or statements (collectively, "forward-looking statements"), including those identified by the expressions "anticipate", "believe", "plan", "estimate", "expect", "intend", "may", "should" and similar expressions to the extent they relate to the Company or its management. The forward- looking statements are not historical facts but reflect current expectations regarding future results or events. This press release contains forward looking statements, including but not limited to statements relating to the Company's expansion plans and future production capacity. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors.

Forward-looking statements are not guarantees of future performance and involve risks, uncertainties and assumptions which are difficult to predict. Factors that could cause the actual results to differ materially from those in forward-looking statements include, but are not limited to, failure to obtain regulatory approval, ability to increase production at the Company's facilities, the continued availability of capital and financing, and general economic, market or business conditions. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance, or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, there can be no assurance that the statements will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, Further, there may be others that cause results not to be as anticipated, estimated or intended and such changes could be material. Public health crises, including the ongoing novel coronavirus (COVID-19) pandemic, could have significant economic and geopolitical impacts that may adversely affect the Company's business, financial condition and/or results of operations.  The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Readers should not place undue reliance on the Company's forward-looking statements.


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

The Conversation (0)
cannabis leaf with gavel

Germany Becomes Ninth European Nation to Legalize Recreational Cannabis

Germany has approved a bill that would legalize the recreational use and possession of cannabis for adults over the age of 18 as of April 1, 2024, becoming the latest European nation to do so.

The matter was taken to a vote on Friday (February 23) morning in the Bundestag, Germany’s parliament. The debate was reportedly heated, but in the end the measure passed with 407 votes for and 226 against.

Under the new law, German adults will be able to legally possess up to 25 grams of cannabis in public places and 50 grams at home. Smoking cannabis in public will also be allowed, as will home cultivation of up to three plants.

Keep reading...Show less

Trulieve to Open Medical Cannabis Dispensary in Pinellas Park, Florida

New Pinellas County location will host grand opening celebration Saturday

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in Pinellas Park, Florida .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
cannabis leaves, ukraine flag

Cannabis Round-Up: Ukraine Legalizes Medical Cannabis, Blüm to Acquire California Stores

Cannabis company Blüm Holdings (OTCQB:BLMH) signed a letter of intent to purchase three California retail locations from Operators Only this week in a bid to expand its business into Sacramento.

Meanwhile, Ukraine passed legislation to legalize medical cannabis use, and Québec's only cannabis retailer reported its results for the third quarter of 2023, showing sales growth. Also, after years of trying to establish an adult-use cannabis market, Virginia's Senate and the House of Delegates approved two separate cannabis sales bills.

Stay up to date on the latest news, trends and policy developments in the cannabis industry with our round-up below.

Keep reading...Show less

Cronos Group Inc. to Hold 2023 Fourth Quarter and Full-Year Earnings Conference Call on February 29, 2024

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company") will hold its 2023 fourth quarter and full-year earnings conference call on Thursday, February 29, 2024 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks.

To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/events-presentations . To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast of the call will be archived for replay on the Company's website.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Trulieve Cannabis Corp. to Hold Fourth Quarter and Full Year 2023 Results Conference Call on February 29, 2024

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., will hold a conference call on Thursday, February 29, 2024 at 8:30 AM Eastern Time following the release of its fourth quarter and full year 2023 financial results.

Trulieve logo (PRNewsfoto/Trulieve Cannabis Corp.)

Chairman, Founder, and Chief Executive Officer Kim Rivers and Chief Financial Officer Wes Getman will participate on the call to review Trulieve's financial and operating results.

Interested parties can join the conference call by dialing in as directed below. Please dial in 15 minutes prior to the call and ask to join the Trulieve Cannabis Corp. call.






North American toll free: 1-844-824-3830

Passcode:

1674609


International: 1-412-542-4136

Passcode:

1674609





A live audio webcast of the conference call will be available at:
https://app.webinar.net/rGl0B9nPzjZ

An archived replay of the webcast will be available at:
https://investors.trulieve.com/events

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com .

Facebook: @Trulieve
Instagram: @Trulieve _
X: @Trulieve

Investor Contact
Christine Hersey , Vice President of Investor Relations
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

Media Contact
Phil Buck , APR, Corporate Communications Manager
+1 (406) 370-6226
Philip.Buck@Trulieve.com

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/trulieve-cannabis-corp-to-hold-fourth-quarter-and-full-year-2023-results-conference-call-on-february-29-2024-302052287.html

SOURCE Trulieve Cannabis Corp.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/February2024/05/c5649.html

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
cannabis leaves, american flag

Cannabis Round-Up: Texas Attorney General Sues Local Cities for Decriminalization Efforts

Texas' attorney general is suing five states for enacting local decriminalization measures.

Meanwhile, Kentucky has introduced a second bill to legalize cannabis, this time with measures that allow for a recreational market, and Florida has passed a bill that would place THC limits on recreational cannabis.

Keep reading for a round-up of this week's top news and trends in the cannabis industry.

Keep reading...Show less

Latest Press Releases

Related News

×